Serum sIgG4, but not sIgA, is involved in induced and natural tolerance to egg allergens

por Vazquez-Ortiz, M, Pascal, M, Alsina, L, Piquer, M, Lozano, J, Martin-Mateos, MA, Plaza, AM
Publicado 2013

Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia

por Deyà-Martínez, A., Alonso-Saladrigues, A., García, A. P., Faura, A., Torrebadell, M., Vlagea, A., Català, A., Esteve-Solé, A., Juan, M., Rives, S., Alsina, L.
Publicado 2020

COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era

por Deyà-Martínez, A., García-García, A., Gonzalez-Navarro, E.A., Yiyi, L., Vlagea, A., Jordan, I., Fumadó, V., Fortuny, C., Español, M., Launes, C., Esteve-Solé, A., Juan, M., Pascal, M., Alsina, L.
Publicado 2021

A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4

por Alsina, L, Israelsson, E, Altman, MC, Dang, KK, Ghandil, P, Israel, L, von Bernuth, H, Baldwin, N, Qin, H, Jin, Z, Banchereau, R, Anguiano, E, Ionan, A, Abel, L, Puel, A, Picard, C, Pascual, V, Casanova, JL, Chaussabel, D
Publicado 2014

PB1938: 4WHIM: EVALUATING MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH WHIM SYNDROME VIA A GLOBAL PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION

por Dale, D. C., Alsina, L., Azar, A., Badolato, R., Bertrand, Y., Deya, A., Dickerson, K. E., Ezra, N., Hasle, H., Kang, H. J., Kiani-Alikhan, S., Kuijpers, T., Kulagin, A., Langguth, D., Levin, C., Neth, O., Peake, J., Rutten, C. E., Shcherbina, A., Tarrant, T. K., Vossen, M. G., Wysocki, C. A., Belschner, A., Cadavid, D., Hu, Y., Jiang, H., MacLeod, R., Tang, W., Tillinger, M., Donadieu, J.
Publicado 2022